Most of the specialty brand/access channel teams we’ve spoken to recently share a similar objective: to maximize the patient/provider...

The recent Asembia Specialty Pharmacy Summit reminded us: Technology will continue to play an increasing role in improving patient outcomes.

Raising awareness and interest in a disease area that is not top of mind is a common problem for the marketing of brands for rare diseases.

Aventria has been facilitating collaborations for 25 years. This is a back-of-the-envelope approach to operationalize a collaboration.

After spending a week at the Asembia 2022 Specialty Pharmacy Summit, it became clear that new approaches are needed to address key...

Effective customer collaborations can deliver great value, such as improved patient outcomes, satisfaction, appropriate use, and care delive

Branded pharmaceutical market access may seem challenging in long-term care (LTC) if you only consider the higher drug cost without

Discover what good looks like in a Pharma-IDN EHR collaboration and how to ensure your key account management team has everything they need

Why a pharma company’s plans to achieve collaborations with health systems may not be meeting expectations. Why some pharma programs may not

The answer is PROBABLY. Aventria has been able to make clients successful by:

In July I was invited to attend and present at a Rare Disease Roundtable hosted by Health Catalyst and McDermott Will & Emery. Aventria had

Brand, payer marketing, market access, and managed markets teams: As you know, the US Department of Health and Human Services (HHS)

Aventria Health Group is a managed markets agency, otherwise known as a market access agency. We work at the intersection of marketing and

Managed markets customers for Pharma are health care organizations with processes (drug coverage policies and management techniques) to ...

Have you reviewed your brand’s value proposition to ensure it continues to clearly resonate with your target customers in the fast...

Brand, payer marketing, market access, and managed markets teams: Are you prepared for a call from the boardroom to review your brand’s...

If you are on the brand, market access, or managed markets team at your pharmaceutical company, likely you are already well aware of the...

More often than ever before, we hear our pharma clients discussing hooking up with technology companies, from a digital health start-up...

As provider incentives move inexorably toward risk- and value-based reimbursement, larger provider groups are implementing standardized...

This is a summary of a recent podcast in which Stacey Richter and Dave Dierk, co-presidents of Aventria, discuss critical success factors...